Document is current
Any future updates will be listed below
-
Authors
Hirano, Yuki https://orcid.org/0000-0002-3976-2278
Kaneko, Hidehiro
Konishi, Takaaki
Itoh, Hidetaka
Matsuda, Satoru
Kawakubo, Hirofumi
Uda, Kazuaki
Matsui, Hiroki
Fushimi, Kiyohide
Daiko, Hiroyuki
Itano, Osamu
Yasunaga, Hideo
Kitagawa, Yuko
- License Information
-
More Information
Article History
First Online: 21 August 2022
Disclosure
: Dr. Kitagawa has received grants from Chugai Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co. Ltd., Yakult Honsha Co. Ltd., Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Tsumura & Co., Kaken Pharmaceutical Co. Ltd., Dainippon Sumitomo Pharma Co. Ltd., EA Pharma Co. Ltd., Eisai Co. Ltd., Otsuka Pharmaceutical Factory Inc., Medicon Inc., Kyowa Hakko Kirin Co. Ltd., Takeda Pharmaceutical Co. Ltd., Toyama Chemical Co. Ltd., Astellas Pharma Inc., Teijin Pharma Limited., Nihon Pharmaceutical Co. Ltd., and Nippon Covidien Inc. as well as lecture fees from Chugai Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co. Ltd., Asahi Kasei Pharma Co. Ltd., Otsuka Pharmaceutical Factory Inc., Ono Pharmaceutical Co. Ltd., Shionogi & Co. Ltd., AstraZeneca K.K., Nippon Covidien Inc., Ethicon Inc., Bristol-Myers Squibb K.K., and Olympus Co. outside the submitted work. No other disclosures are reported.
